121 related articles for article (PubMed ID: 23030610)
1. Dipeptide inhibitors of thermolysin and angiotensin I-converting enzyme.
Khan MT; Dedachi K; Matsui T; Kurita N; Borgatti M; Gambari R; Sylte I
Curr Top Med Chem; 2012; 12(16):1748-62. PubMed ID: 23030610
[TBL] [Abstract][Full Text] [Related]
2. Novel peptidomimics as angiotensin-converting enzyme inhibitors: a combinatorial approach.
Bala M; Qadar Pasha MA; Bhardwaj DK; Pasha S
Bioorg Med Chem; 2002 Nov; 10(11):3685-91. PubMed ID: 12213484
[TBL] [Abstract][Full Text] [Related]
3. Identification and Inhibitory Mechanism of Angiotensin I-Converting Enzyme Inhibitory Peptides Derived from Bovine Hemoglobin.
Wang Y; Jiang Y; Yin Y; Liu J; Ding L; Liu J; Zhang T
Protein J; 2017 Jun; 36(3):166-173. PubMed ID: 28321677
[TBL] [Abstract][Full Text] [Related]
4. Study on the domain selective inhibition of angiotensin-converting enzyme (ACE) by food-derived tyrosine-containing dipeptides.
Song CC; Qiao BW; Zhang Q; Wang CX; Fu YH; Zhu BW
J Food Biochem; 2021 Jul; 45(7):e13779. PubMed ID: 34060658
[TBL] [Abstract][Full Text] [Related]
5. Design of orally active dual inhibitors of neutral endopeptidase and angiotensin-converting enzyme with long duration of action.
Fournie-Zaluski MC; Coric P; Thery V; Gonzalez W; Meudal H; Turcaud S; Michel JB; Roques BP
J Med Chem; 1996 Jun; 39(13):2594-608. PubMed ID: 8691458
[TBL] [Abstract][Full Text] [Related]
6. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
[TBL] [Abstract][Full Text] [Related]
7. Mapping the active site of angiotensin-converting enzyme by transferred NOE spectroscopy.
Mayer M; Meyer B
J Med Chem; 2000 Jun; 43(11):2093-9. PubMed ID: 10841788
[TBL] [Abstract][Full Text] [Related]
8. The binding of L-valyl-L-tryptophan to crystalline thermolysin illustrates the mode of interaction of a product of peptide hydrolysis.
Holden HM; Matthews BW
J Biol Chem; 1988 Mar; 263(7):3256-60. PubMed ID: 3343246
[TBL] [Abstract][Full Text] [Related]
9. The design and properties of N-carboxyalkyldipeptide inhibitors of angiotensin-converting enzyme.
Patchett AA; Cordes EH
Adv Enzymol Relat Areas Mol Biol; 1985; 57():1-84. PubMed ID: 2994404
[TBL] [Abstract][Full Text] [Related]
10. Thiol-based angiotensin-converting enzyme 2 inhibitors: P1' modifications for the exploration of the S1' subsite.
Deaton DN; Graham KP; Gross JW; Miller AB
Bioorg Med Chem Lett; 2008 Mar; 18(5):1681-7. PubMed ID: 18243695
[TBL] [Abstract][Full Text] [Related]
11. Specific interactions and binding energies between thermolysin and potent inhibitors: molecular simulations based on ab initio molecular orbital method.
Hirakawa T; Fujita S; Ohyama T; Dedachi K; Khan MT; Sylte I; Kurita N
J Mol Graph Model; 2012 Mar; 33():1-11. PubMed ID: 22112671
[TBL] [Abstract][Full Text] [Related]
12. The Dynamic Nonprime Binding of Sampatrilat to the C-Domain of Angiotensin-Converting Enzyme.
Sharma RK; Espinoza-Moraga M; Poblete H; Douglas RG; Sturrock ED; Caballero J; Chibale K
J Chem Inf Model; 2016 Dec; 56(12):2486-2494. PubMed ID: 27959521
[TBL] [Abstract][Full Text] [Related]
13. Characterization of new milk-derived inhibitors of angiotensin converting enzyme in vitro and in vivo.
Fuglsang A; Nilsson D; Nyborg NC
J Enzyme Inhib Med Chem; 2003 Oct; 18(5):407-12. PubMed ID: 14692507
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin I-converting enzyme inhibitory activity of gelatin hydrolysates and identification of bioactive peptides.
Herregods G; Van Camp J; Morel N; Ghesquière B; Gevaert K; Vercruysse L; Dierckx S; Quanten E; Smagghe G
J Agric Food Chem; 2011 Jan; 59(2):552-8. PubMed ID: 21174470
[TBL] [Abstract][Full Text] [Related]
15. Structural features of angiotensin-I converting enzyme catalytic sites: conformational studies in solution, homology models and comparison with other zinc metallopeptidases.
Spyroulias GA; Galanis AS; Pairas G; Manessi-Zoupa E; Cordopatis P
Curr Top Med Chem; 2004; 4(4):403-29. PubMed ID: 14965309
[TBL] [Abstract][Full Text] [Related]
16. Identification of post-digestion angiotensin-I converting enzyme (ACE) inhibitory peptides from soybean protein Isolate: Their production conditions and in silico molecular docking with ACE.
Xu Z; Wu C; Sun-Waterhouse D; Zhao T; Waterhouse GIN; Zhao M; Su G
Food Chem; 2021 May; 345():128855. PubMed ID: 33340899
[TBL] [Abstract][Full Text] [Related]
17. ACE-domain selectivity extends beyond direct interacting residues at the active site.
Cozier GE; Lubbe L; Sturrock ED; Acharya KR
Biochem J; 2020 Apr; 477(7):1241-1259. PubMed ID: 32195541
[TBL] [Abstract][Full Text] [Related]
18. Understanding the dual mechanism of bioactive peptides targeting the enzymes involved in Renin Angiotensin System (RAS): An
Gunalan S; Somarathinam K; Bhattacharya J; Srinivasan S; Jaimohan SM; Manoharan R; Ramachandran S; Kanagaraj S; Kothandan G
J Biomol Struct Dyn; 2020 Oct; 38(17):5044-5061. PubMed ID: 31755358
[TBL] [Abstract][Full Text] [Related]
19. Specific interactions and binding free energies between thermolysin and dipeptides: molecular simulations combined with ab initio molecular orbital and classical vibrational analysis.
Dedachi K; Hirakawa T; Fujita S; Khan MT; Sylte I; Kurita N
J Comput Chem; 2011 Nov; 32(14):3047-57. PubMed ID: 21815174
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of bacterial and human zinc-metalloproteases by bisphosphonate- and catechol-containing compounds.
Rahman F; Nguyen TM; Adekoya OA; Campestre C; Tortorella P; Sylte I; Winberg JO
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):819-830. PubMed ID: 33757387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
